Shares of The Beauty Health Company (NASDAQ:SKIN – Get Free Report) have earned a consensus rating of “Hold” from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $1.3750.
SKIN has been the topic of several research analyst reports. Weiss Ratings cut shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, July 23rd. TD Cowen decreased their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating for the company in a research report on Wednesday, August 12th. Roth Capital reaffirmed a “buy” rating and set a $2.00 price target (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Finally, Zacks Research downgraded Beauty Health from a “strong-buy” rating to a “hold” rating in a report on Monday, July 20th.
Check Out Our Latest Analysis on SKIN
Beauty Health Price Performance
Beauty Health (NASDAQ:SKIN – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.02) EPS for the quarter, hitting the consensus estimate of ($0.02). The firm had revenue of $72.11 million during the quarter, compared to analysts’ expectations of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. Research analysts expect that Beauty Health will post -0.16 EPS for the current year.
Hedge Funds Weigh In On Beauty Health
Several large investors have recently added to or reduced their stakes in the company. Capricorn Fund Managers Ltd bought a new stake in shares of Beauty Health during the 1st quarter valued at about $17,270,000. Renaissance Technologies LLC raised its stake in Beauty Health by 29.6% during the 1st quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares in the last quarter. Bank of America Corp DE lifted its holdings in Beauty Health by 19.2% in the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after purchasing an additional 17,088 shares during the period. Diversified Trust Co acquired a new stake in shares of Beauty Health in the 1st quarter worth approximately $25,000. Finally, MTM Investment Management LLC boosted its stake in Beauty Health by 114.0% during the 4th quarter. MTM Investment Management LLC now owns 26,218 shares of the company’s stock valued at $36,000 after purchasing an additional 13,968 shares in the last quarter. 93.26% of the stock is currently owned by institutional investors.
Beauty Health Company Profile
Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.
Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.
Recommended Stories
- Five stocks we like better than Beauty Health
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
